IL-6’s activation of STAT3 appears to protect the epithelium of the GI tract from apoptosis and stimulates regeneration [53, 64, 77], and high IL-6 levels have been associated with increased colorectal cancer tumor risk [65]. Here, STAT3 is linked to neoplasm.